Drugs for Pain Management Market Insights, Global Outlook and Forecast 2022-2028
Drugs for Pain Management Market Insights, Global Outlook and Forecast 2022-2028
Analysis of the Drugs for Pain Management Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
The latest research study released by Market IntelliX evaluates market size and forecasts of Drugs for Pain Management in Global, including the following market information:
Global Drugs for Pain Management Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs for Pain Management market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Opioid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Pain Management include GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Drugs for Pain Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Drugs for Pain Management Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Pain Management Market Segment Percentages, by Type, 2021 (%)
Generic Opioid
Branded Opioids
NSAIDs
Others
Global Drugs for Pain Management Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Pain Management Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Others
Global Drugs for Pain Management Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Pain Management Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Pain Management revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs for Pain Management revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Drugs for Pain Management Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Pain Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Pain Management Overall Market Size
2.1 Global Drugs for Pain Management Market Size: 2021 VS 2028
2.2 Global Drugs for Pain Management Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Pain Management Players in Global Market
3.2 Top Global Drugs for Pain Management Companies Ranked by Revenue
3.3 Global Drugs for Pain Management Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Pain Management Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs for Pain Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Pain Management Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Pain Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Pain Management Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs for Pain Management Market Size Markets, 2021 & 2028
4.1.2 Generic Opioid
4.1.3 Branded Opioids
4.1.4 NSAIDs
4.1.5 Others
4.2 By Type - Global Drugs for Pain Management Revenue & Forecasts
4.2.1 By Type - Global Drugs for Pain Management Revenue, 2017-2022
4.2.2 By Type - Global Drugs for Pain Management Revenue, 2023-2028
4.2.3 By Type - Global Drugs for Pain Management Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Pain Management Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Drugs for Pain Management Revenue & Forecasts
5.2.1 By Application - Global Drugs for Pain Management Revenue, 2017-2022
5.2.2 By Application - Global Drugs for Pain Management Revenue, 2023-2028
5.2.3 By Application - Global Drugs for Pain Management Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drugs for Pain Management Market Size, 2021 & 2028
6.2 By Region - Global Drugs for Pain Management Revenue & Forecasts
6.2.1 By Region - Global Drugs for Pain Management Revenue, 2017-2022
6.2.2 By Region - Global Drugs for Pain Management Revenue, 2023-2028
6.2.3 By Region - Global Drugs for Pain Management Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drugs for Pain Management Revenue, 2017-2028
6.3.2 US Drugs for Pain Management Market Size, 2017-2028
6.3.3 Canada Drugs for Pain Management Market Size, 2017-2028
6.3.4 Mexico Drugs for Pain Management Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drugs for Pain Management Revenue, 2017-2028
6.4.2 Germany Drugs for Pain Management Market Size, 2017-2028
6.4.3 France Drugs for Pain Management Market Size, 2017-2028
6.4.4 U.K. Drugs for Pain Management Market Size, 2017-2028
6.4.5 Italy Drugs for Pain Management Market Size, 2017-2028
6.4.6 Russia Drugs for Pain Management Market Size, 2017-2028
6.4.7 Nordic Countries Drugs for Pain Management Market Size, 2017-2028
6.4.8 Benelux Drugs for Pain Management Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drugs for Pain Management Revenue, 2017-2028
6.5.2 China Drugs for Pain Management Market Size, 2017-2028
6.5.3 Japan Drugs for Pain Management Market Size, 2017-2028
6.5.4 South Korea Drugs for Pain Management Market Size, 2017-2028
6.5.5 Southeast Asia Drugs for Pain Management Market Size, 2017-2028
6.5.6 India Drugs for Pain Management Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drugs for Pain Management Revenue, 2017-2028
6.6.2 Brazil Drugs for Pain Management Market Size, 2017-2028
6.6.3 Argentina Drugs for Pain Management Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Pain Management Revenue, 2017-2028
6.7.2 Turkey Drugs for Pain Management Market Size, 2017-2028
6.7.3 Israel Drugs for Pain Management Market Size, 2017-2028
6.7.4 Saudi Arabia Drugs for Pain Management Market Size, 2017-2028
6.7.5 UAE Drugs for Pain Management Market Size, 2017-2028
7 Players Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Drugs for Pain Management Major Product Offerings
7.1.4 GSK Drugs for Pain Management Revenue in Global Market (2017-2022)
7.1.5 GSK Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs for Pain Management Major Product Offerings
7.2.4 Pfizer Drugs for Pain Management Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Grunenthal
7.3.1 Grunenthal Corporate Summary
7.3.2 Grunenthal Business Overview
7.3.3 Grunenthal Drugs for Pain Management Major Product Offerings
7.3.4 Grunenthal Drugs for Pain Management Revenue in Global Market (2017-2022)
7.3.5 Grunenthal Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Drugs for Pain Management Major Product Offerings
7.4.4 Sanofi Drugs for Pain Management Revenue in Global Market (2017-2022)
7.4.5 Sanofi Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Drugs for Pain Management Major Product Offerings
7.5.4 Bayer Drugs for Pain Management Revenue in Global Market (2017-2022)
7.5.5 Bayer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Drugs for Pain Management Major Product Offerings
7.6.4 AstraZeneca Drugs for Pain Management Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Drugs for Pain Management Major Product Offerings
7.7.4 Eli Lilly Drugs for Pain Management Revenue in Global Market (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Endo
7.8.1 Endo Corporate Summary
7.8.2 Endo Business Overview
7.8.3 Endo Drugs for Pain Management Major Product Offerings
7.8.4 Endo Drugs for Pain Management Revenue in Global Market (2017-2022)
7.8.5 Endo Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Drugs for Pain Management Major Product Offerings
7.9.4 Merck Drugs for Pain Management Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 Yunnan Baiyao
7.10.1 Yunnan Baiyao Corporate Summary
7.10.2 Yunnan Baiyao Business Overview
7.10.3 Yunnan Baiyao Drugs for Pain Management Major Product Offerings
7.10.4 Yunnan Baiyao Drugs for Pain Management Revenue in Global Market (2017-2022)
7.10.5 Yunnan Baiyao Key News
7.11 Teikoku Seiyaku
7.11.1 Teikoku Seiyaku Corporate Summary
7.11.2 Teikoku Seiyaku Business Overview
7.11.3 Teikoku Seiyaku Drugs for Pain Management Major Product Offerings
7.11.4 Teikoku Seiyaku Drugs for Pain Management Revenue in Global Market (2017-2022)
7.11.5 Teikoku Seiyaku Key News
7.12 Teva
7.12.1 Teva Corporate Summary
7.12.2 Teva Business Overview
7.12.3 Teva Drugs for Pain Management Major Product Offerings
7.12.4 Teva Drugs for Pain Management Revenue in Global Market (2017-2022)
7.12.5 Teva Key News
7.13 J&J
7.13.1 J&J Corporate Summary
7.13.2 J&J Business Overview
7.13.3 J&J Drugs for Pain Management Major Product Offerings
7.13.4 J&J Drugs for Pain Management Revenue in Global Market (2017-2022)
7.13.5 J&J Key News
7.14 Assertio Therapeutics
7.14.1 Assertio Therapeutics Corporate Summary
7.14.2 Assertio Therapeutics Business Overview
7.14.3 Assertio Therapeutics Drugs for Pain Management Major Product Offerings
7.14.4 Assertio Therapeutics Drugs for Pain Management Revenue in Global Market (2017-2022)
7.14.5 Assertio Therapeutics Key News
7.15 Allergan
7.15.1 Allergan Corporate Summary
7.15.2 Allergan Business Overview
7.15.3 Allergan Drugs for Pain Management Major Product Offerings
7.15.4 Allergan Drugs for Pain Management Revenue in Global Market (2017-2022)
7.15.5 Allergan Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Drugs for Pain Management Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|